不同术式子宫肌瘤切除对患者卵巢功能及性功能的影响

目的：比较两种子宫肌瘤切除术对患者卵巢与性功能的影响。方法将32例子宫肌瘤患者采取随机数字表法分为观察组与对照组，对照组行子宫全切除手术，观察组行阴式子宫肌瘤剔除手术，观察术后患者卵巢功能与性功能变化。结果观察组术后促性腺激素（6．52±1．13） mIU／L，黄体生成素（7．62±2．01）mIU／L；对照组术后促性腺激素（8．65±2．67）mIU／L，黄体生成素（9．43±2．89）mIU／L，两组差异均有统计学意义（t＝2．939、2．057，均P＜0．05）。观察组术后性功能各维度评分：性欲（133．47±26．29）分，性唤起（131.03±22．19）分，性高潮（139．93±26．79）分，性心理（136．27±31．05）分，性行为异常症状（136．24±33.22）分，射精时间（141．29±33．71）分，均高于对照组（ t＝2．778、2．691、2．550、1．988、1．979、3．496，均P＜0．05）。结论阴式子宫肌瘤剔除手术对患者卵巢功能及性功能影响较小，因此应建议子宫肌瘤患者尽量保留子宫，提高患者术后生活质量与内分泌系统的稳定性。

The influence of different surgery strategies on ovarian function and the sexual function of the patients with uterine fibroid

Objective To analyze two kinds of hysteromyoma resection for patients with ovarian and sexual function.Methods 32 patients with uterine fibroids were based on different surgical procedure was divided into the observation group and control group,the control group total excision of the uterine surgery,observation group Yin type uterine fibroids rejecting operation,the postoperative patients with ovarian function and function change were observed. Results Gonadotropin in postoperative observation group was （6.52 ±1.13） mIU/L,luteinizing hormone （7.62 ± 2.01）mIU/L;Postoperative gonadotropin controls （8.65 ±2.67） mIU/L,luteinizing hormone （9.43 ±2.89） mIU/L, there was statistically significant difference between the two group（t=2.939,2.057,all P〈0.05）.Observation group of patients with postoperative sexual function in each dimension score：sexual desire （133.47 ±26.29） points,sexual arousal （131.03 ±22.19） points,orgasm （139.93 ±26.79）,（136.27 ±31.05）,psychological sex abnormalities （136.24 ±33.22）points,ejaculation time （141.29 ±33.71）points were higher than those of the control group（t=2.778,2.691,2.550,1.988,1.979,3.496,all P〈0.05）.Conclusion Yin uterine fibroids eliminate surgery for patients has less effects on ovarian function and sexual function,so patients with uterine fibroids should be suggested to retain the womb,in order to improve patients postoperative quality of life and the stability of the endocrine system.